Combination of rituximab with chemotherapy in diffuse large B-cell lymphoma. Evaluation in daily practice before and after approval of rituximab in this indication-Reference-Cited by-同舟云学术

Combination of rituximab with chemotherapy in diffuse large B-cell lymphoma. Evaluation in daily practice before and after approval of rituximab in this indication

Published:2008-09 Issue:3 Volume:26 Page:139-147
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematol. Oncol.

Author:

Ghesquières Hervé,Ferlay Céline,Sebban Catherine,Chassagne Catherine,Carausu Liana,Gargi Thérèse,Favier Bertrand,Philip Irène,Blay Jean-Yves,Biron Pierre

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference23 articles.

1. New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project;Armitage;J Clin Oncol,1998

2. State-of-the-art therapeutics: diffuse large B-cell lymphoma;Coiffier;J Clin Oncol,2005

3. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma;Coiffier;N Engl J Med,2002

4. Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma;Habermann;J Clin Oncol,2006

5. Six vs. eight cycles of bi-weekly CHOP-14 with or without rituximab for elderly patients with diffuse large B-cell lymphoma (DLBCL): results of the completed RICOVER-60 trial of the German high-grade non-Hodgkin lymphoma study group (DSHNHL);Pfreundschuh;Blood,2006

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic significance of Epstein–Barr virus DNA detection in pretreatment serum in diffuse large B‐cell lymphoma;Cancer Science;2015-10-07

2. Impact of the introduction of rituximab in first-line follicular lymphoma: a retrospective study of 247 unselected patients referred to a single institution with a long-term follow-up;Hematological Oncology;2014-02-05

3. Differences in outcome for consecutive patients with diffuse large B-cell lymphoma before and after the advent of rituximab: a single-center experience;Hematology;2013-03

4. Self-Assembled Antibody Multimers through Peptide Nucleic Acid Conjugation;Journal of the American Chemical Society;2012-12-21

5. Manganese Porphyrin, MnTE-2-PyP5+, Acts as a Pro-Oxidant to Potentiate Glucocorticoid-Induced Apoptosis in Lymphoma Cells;Free Radical Biology and Medicine;2012-04